MHSI

Call for an appointment

(877) 784-3667

Richard D. Fessler, M.D.

BACKGROUND: The promising results of the Solitaire Flow Restoration (FR) With the Intention for Thrombectomy (SWIFT) trial recently led to Food and Drug Administration (FDA) approval of theSolitaire FR stent retriever device for recanalization of cerebral vessels in patients with acute ischemic stroke. 

OBJECTIVE: To report the early postmarket experience with this device since its FDA approval in the United States, which has not been previously described.

EXPERTISE makes the difference

Current patients can now request to schedule or change an appointment through the patient portal and request prescription refills.